[Clinical, molecular and cytogenetic characteristics of newly diagnosed adult acute myeloid patients with TP53 gene mutation]

Zhonghua Xue Ye Xue Za Zhi. 2019 Jun 14;40(6):528-531. doi: 10.3760/cma.j.issn.0253-2727.2019.06.016.

[Article in Chinese]

Authors

W M Chen¹, H Liu², L D Li¹, L Y Long¹, Y Y Lai¹, H X Shi¹, X S Zhao¹, H Jiang¹, Q Jiang¹, Y R Liu¹, Y Z Qin¹

Affiliations

¹ Institute of Hematology, Peking University Peoples'Hospital, Beijing 100044, China.
² Xinjiang Uygur Autonomous Region People's Hospital, Urumchi 830001, China.

PMID: 31340630
PMCID: PMC7342400
DOI: 10.3760/cma.j.issn.0253-2727.2019.06.016

No abstract available

MeSH terms

Adult
Cytogenetics
Genes, p53*
Humans
Leukemia, Myeloid, Acute* / genetics
Mutation
Prognosis
Tumor Suppressor Protein p53 / genetics*

Substances

TP53 protein, human
Tumor Suppressor Protein p53

Grants and funding

基金项目：国家自然科学基金（81870125）